1 completed, 1 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow plitidepsin: new trials by email Literature Review of plitidepsin trials Research Report on plitidepsin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection Plitidepsin, Dexamethasone, Remdesivir - COVID-19 Infection | Phase 3 | Terminated | PharmaMar | 205 | 2021-06-04 | 2025-02-21 |
| Aplidin - Dexamethasone in Relapsed/Refractory Myeloma Plitidepsin, Dexamethasone - Relapsed/Refractory Multiple Myeloma | Phase 3 | Completed | PharmaMar | 255 | 2010-06-01 | 2020-11-10 |
COVID-19 (1) · Multiple Myeloma (1)
PharmaMar (2)
France (2) · Greece (2) · Spain (2) · Australia (1) · Austria (1) · Belgium (1) · Brazil (1) · Bulgaria (1) · Colombia (1) · Czechia (1) · Germany (1) · Ireland (1) · Italy (1) · Mexico (1) · Netherlands (1)